what's the difference semaglutide and tirzepatide vs for Weight Loss Comparative safety and side effects

The treatment: Semaglutide and other GLP-1 agonists typically cause delayed gastric emptying, which means they slow the rate at which the stomach empties its contents into the intestines

It asks about your medical history, current weight, past attempts at weight loss, and general lifestyle questions

[9] According to the FDA prescribing information, nausea occurred in 12-24% of patients, vomiting in 2-11%, and diarrhea in 7-17%, with rates varying by dose (5 mg, 10 mg, or 15 mg weekly)

The TRIUMPH-4 safety profile is qualitatively similar to semaglutide and tirzepatide (GI adverse events dominate) but the rate of nausea, vomiting, and diarrhea is higher than previously seen in the class, and dropout at 12 mg is higher than at 9 mg